News & Articles

Collaboration focuses on education, early testing, and improved access to care for patients at risk of HDFN

Collaboration integrates AI image analysis with digital pathology workflows to support consistent biomarker scoring

New developments in microbial identification, sepsis diagnostics, and NGS workflows support faster clinical decision-making

One lab shares its experience switching to Streck’s quality control solution for molecular diagnostics testing

Multiplex PCR test supports rapid detection of multidrug‑resistant organisms in hospital settings

Strengthening local presence and customer support in a high-growth life sciences market

New RUO parameters enable deeper insights from routine CBC testing without additional workflow steps

New digital and biomarker-integrated solution supports early detection, risk assessment, and disease monitoring

Proposed regulatory approach aims to enable earlier patient access and support innovative trial designs

2026 Surviving Sepsis Campaign Guidelines and U.S. SEPSIS Act reinforce the need to close persistent therapeutic gaps in septic shock and improve survival through personalized, evidence-based approaches

Integrated diagnostics and digital health platform aims to enable earlier intervention and improve outcomes in chronic kidney disease

First commercial sale of VertX, the cutting-edge, label-free live microscope module at William Morey General Hospital, enabling high‑resolution imaging of biopsies to support infection research and personalized treatment

Lumipulse G pTau 217 Plasma test supports identification of amyloid pathology in patients with cognitive decline

As Candida auris and carbapenem-resistant Enterobacterales rise, join us online to explore how emerging approaches such as next-generation sequencing and rapid susceptibility testing may support antimicrobial stewardship — plus, ask your questions in the live Q&A

HiArc Ctrl combines embedded hardware and software tools to streamline prototyping and regulated workflow development

Elecsys pTau217 is the first single-assay blood test designed to identify or rule out amyloid pathology across primary and secondary care

Study demonstrates how RNA‑based analysis could enable early prediction of clinical outcomes across multiple conditions

Acquisition strengthens Roche’s digital pathology and companion diagnostic portfolio to advance precision medicine

Explore advances in lab testing methods moving food allergy diagnosis beyond skin pricks and into molecular precision

Collaboration integrates LucentAD Complete into AI‑driven clinical workflows to support earlier detection and treatment decisions

Approval by Japan’s MHLW enables use of MyChoice Test as a companion diagnostic for Lynparza in prostate cancer

Certification reaffirms assay results are aligned with specialized mass spectrometry testing method

Elecsys pTau-181 test helps clinicians rule out Alzheimer's disease by identifying patients unlikely to have amyloid pathology

New MDx‑Chex for RLP controls support full‑process verification for respiratory molecular assays